Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Turner

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Allergy and Clinical Immunology|March 1, 1989
Dermal mast cell releasability and end organ responsiveness in atopic and nonatopic dogsC R Turner, M J Darowski, H A Sampson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4C R Turner, V L Cohan, J B Cheng, et al.
Proceedings. Biological Sciences|November 25, 2016
Intralocus sexual conflict and insecticide resistanceM F Hawkes, C E Gamble, E C R Turner, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1997
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitorK F Wright, C R Turner, R Jayasinghe-Beck, et al.
Circulatory Shock|June 1, 1991
Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibitionC R Turner, M N Lackey, M F Quinlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633V L Cohan, H J Showell, D A Fisher, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
The Journal of Clinical Investigation|January 15, 1996
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthmaC R Turner, R Breslow, M J Conklyn, et al.
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Allergy and Clinical Immunology|March 1, 1989
Dermal mast cell releasability and end organ responsiveness in atopic and nonatopic dogsC R Turner, M J Darowski, H A Sampson, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4C R Turner, V L Cohan, J B Cheng, et al.
Proceedings. Biological Sciences|November 25, 2016
Intralocus sexual conflict and insecticide resistanceM F Hawkes, C E Gamble, E C R Turner, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1997
Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitorK F Wright, C R Turner, R Jayasinghe-Beck, et al.
Circulatory Shock|June 1, 1991
Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibitionC R Turner, M N Lackey, M F Quinlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633V L Cohan, H J Showell, D A Fisher, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomyJ B Cheng, J W Watson, C J Pazoles, et al.
The Journal of Clinical Investigation|January 15, 1996
In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthmaC R Turner, R Breslow, M J Conklyn, et al.
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Pageof 4